10-Q: Selectis Health Reports Strong Net Income Driven by Asset Sales

Sentiment:

Quarterly Report


Selectis Health, Inc. reported a significant increase in net income for the six months ended June 30, 2026, primarily driven by substantial gains from the sale of four Georgia facilities, alongside new management fee revenue.

Capital raiseThe company's ability to continue as a going concern is contingent upon seeking additional capital through the issuance of debt or equity securities, or the sale of assets.The merger agreement with Black Pearl Equities II, LLC includes a cash tender offer of $5.75 per share, which represents a potential capital event for shareholders.
Better than expectedNet income for the six months ended June 30, 2026, was $14.6 million, a significant improvement from a net loss of $0.96 million in the prior year period.The company realized a gain of $19.05 million from the sale of assets, which substantially boosted profitability.Total liabilities decreased by approximately 39% from $39.2 million to $23.5 million, largely due to debt repayment from asset sale proceeds.Total stockholders' equity (deficit) improved significantly from a deficit of $6.6 million to a positive $8.0 million.

Summary

  • Selectis Health, Inc. reported a net income of $14.6 million for the six months ended June 30, 2026, a significant improvement from a net loss of $0.96 million in the prior year period.
  • This turnaround was largely due to a $19 million gain on the sale of four Georgia facilities, which generated $28.9 million in gross proceeds.
  • Healthcare revenue decreased by 44% to $11.8 million due to these asset sales, but was partially offset by new management fee revenue of $0.22 million.
  • Operating expenses decreased by 27% to $15.4 million, primarily due to lower property taxes, insurance, and other operating costs associated with the divested facilities.
  • The company's liquidity remains a concern, with a working capital of $0.2 million as of June 30, 2026, and substantial doubt about its ability to continue as a going concern.
  • The company has entered into a merger agreement with Black Pearl Equities II, LLC, proposing a cash tender offer of $5.75 per share.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive due to significant gains from asset sales and a substantial increase in net income, despite ongoing concerns about liquidity and internal control weaknesses.

Positives

  • Achieved a net income of $14.6 million for the six months ended June 30, 2026, a substantial improvement from a net loss of $0.96 million in the same period of 2025.
  • Generated $19.05 million in gains from the sale of assets (four Georgia facilities), contributing significantly to the positive net income.
  • Secured $28.9 million in gross proceeds from the sale of four Georgia facilities in January and May 2026.
  • Initiated management fee revenue, totaling $0.22 million for the six months ended June 30, 2026, indicating a new revenue stream.
  • Reduced overall expenses, with property taxes, insurance, and other operating expenses decreasing by 37% to $10.2 million for the six months ended June 30, 2026.
  • The accumulated deficit significantly decreased from $21.2 million at December 31, 2025, to $6.6 million at June 30, 2026.

Negatives

  • Healthcare revenue decreased by 44% to $11.8 million for the six months ended June 30, 2026, due to the sale of four facilities.
  • The company has substantial doubt about its ability to continue as a going concern, citing historical losses and projected cash needs.
  • Working capital was only $0.2 million as of June 30, 2026.
  • There are material weaknesses in internal control over financial reporting related to disclosure controls, internal control over financial reporting, and complex equity transactions.
  • The company's cash flows from operating activities were negative at $4.3 million for the six months ended June 30, 2026.
  • The company has a history of losses and reliance on debt and equity sales to meet cash demands.

Risks

  • Substantial doubt exists about the Company's ability to continue as a going concern, contingent upon successful execution of management's plan to improve liquidity and profitability.
  • The company's ability to continue as a going concern is dependent on raising additional funds through equity and/or debt securities or asset sales.
  • Failure to execute strategic plans to improve liquidity and profitability could negatively impact future operations.
  • The senior care industry faces significant increases in personal injury/wrongful death claims and potential regulatory scrutiny, which could lead to material adverse financial losses.
  • Material weaknesses in internal control over financial reporting could lead to a material misstatement in financial statements.
  • The merger agreement is subject to conditions, including a minimum tender condition of 70% of outstanding shares and a cap on appraisal rights exercised by stockholders.

Future Outlook

The company's ability to continue as a going concern is contingent upon the successful execution of its plan to improve liquidity and profitability, which includes increasing revenue, controlling expenses, and seeking additional capital. The company cannot predict with certainty the outcome of these actions. A merger agreement has been entered into, proposing a cash tender offer of $5.75 per share.

Management Comments

  • Management acknowledges substantial doubt about the Company's ability to continue as a going concern, contingent upon successful execution of their plan to improve liquidity and profitability.
  • Management believes they are following all applicable laws and regulations governing Medicare, Medicaid, and other federal healthcare programs in all material respects, but notes potential for future government review and interpretation.
  • Management evaluated the effectiveness of disclosure controls and procedures and concluded they were not effective as of June 30, 2026.
  • Management identified material weaknesses in internal control over financial reporting related to disclosure controls, internal control over financial reporting, and complex equity transactions.

Industry Context

StockSavvy.ai notes that Selectis Health operates in the senior housing and post-acute/skilled nursing sector. The company's strategic shift towards asset sales and management fee arrangements reflects a broader industry trend of optimizing portfolios and exploring diversified revenue streams. However, the persistent going concern issues and internal control weaknesses are significant headwinds.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control DeficienciesMaterial weaknesses identified in disclosure controls and procedures, internal control over financial reporting, and complex equity transactions.June 30, 2026Reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information in a timely manner.

Legal Proceedings

  • The company and its subsidiaries are subject to claims of negligence resulting in injury or death to residents, for which they maintain comprehensive general liability and professional liability insurance.
  • The senior care industry is experiencing increased claims and awards for alleged negligence, posing potential material adverse financial losses.
  • There is additional litigation incidental to the business, none of which is currently considered material to financial position, results of operations, or cash flows.
  • The company is subject to scrutiny by governmental regulators, which could result in litigation or claims related to regulatory compliance matters.

Related Party Transactions

  • In 2017, $600,000 in senior secured notes were sold, of which $425,000 were to related parties.
  • During 2018, $875,000 of senior secured notes extended to October 31, 2021, were to related parties.
  • On March 3, 2020, the company sold $100,000 in Units of 11% Senior Secured Notes to a related party.
  • Senior Secured Promissory Notes - Related Parties had a balance of $775,000 as of December 31, 2025, which was paid off during the six months ended June 30, 2026.

Stakeholder Impact

  • Shareholders: A tender offer of $5.75 per share is proposed, providing a potential exit opportunity. However, the ongoing going concern issues and internal control weaknesses create uncertainty.
  • Creditors: The company's ability to service debt is a concern, though recent asset sales have reduced overall liabilities.
  • Employees: Potential impact from ongoing operational challenges and the proposed merger.
  • Customers (Residents/Patients): Continued provision of care is expected, but operational stability is a factor.

Next Steps

  • The company is pursuing a plan to improve liquidity and profitability, including increasing revenue, controlling operating expenses, and seeking additional capital.
  • A cash tender offer of $5.75 per share is proposed by Black Pearl Equities II, LLC, subject to certain conditions.
  • Following the tender offer, a merger is planned where the company would become a wholly owned subsidiary of Purchaser.
  • The company plans to implement multi-level review in 2026 to address material weaknesses in internal controls.

Key Dates

DateDescription
2025-12-31Year-end balance sheet date.
2026-01-01Beginning of the six-month period ended June 30, 2026.
2026-01-31Providence HR, LLC and related transactions.
2026-02-28Maturity date for Senior Secured Promissory Notes and Senior Secured Promissory Notes - Related Party.
2026-03-05Company executed Purchase and Sale Agreements for remaining Georgia facilities.
2026-03-31End of the first quarter of 2026.
2026-04-01Beginning of the second quarter of 2026.
2026-04-12Initial maturity date for Commercial Line of Credit Agreement and Note with Southern Bank.
2026-05-01Sale of two additional Georgia facilities closed.
2026-06-22Company entered into an Agreement and Plan of Merger with Black Pearl Equities II, LLC.
2026-06-30Quarter-end balance sheet date and end of the six-month period.
2026-08-10Company redeemed all remaining outstanding shares of Series D Convertible Preferred stock.
2026-08-21As of date for outstanding shares of Common Stock.
2026-08-24Date of report signatures.
2026-11-14Maturity date for a Commercial Line of Credit Agreement and Note with Southern Bank.
2026-12-14Extended maturity date for a Commercial Line of Credit Agreement and Note with Southern Bank.
2027-12-31Expiration date for warrants issued with 11% Senior Secured Notes.

Recommendation

hold

The company has demonstrated improved profitability through asset sales and has a potential acquisition offer at a premium. However, significant going concern issues and material weaknesses in internal controls warrant a cautious 'hold' stance until these fundamental risks are addressed and the merger outcome is certain.

Keywords

Healthcare Facilities, Asset Sale, Merger Agreement, Going Concern, Financial Reporting, Net Income, Operating Expenses, Liquidity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.